JIUMAOJIU (09922) spent HK$1,001,100 on April 22 to repurchase 519,000 shares.

18:41 22/04/2026

"09922 announced that on April 22, 2026, the company spent HKD 1.011 million to repurchase 519,000 shares at a repurchase price of HKD 1.92-1.94 per share."

JIUMAOJIU (09922) announced on April 22, 2026, that the company will spend 1.011 million Hong Kong dollars to repurchase 519,000 shares, with a repurchase price of 1.92-1.94 Hong Kong dollars per share.

GF SEC(01776): "23 GF04" interest payment redemption and delisting, "23 GF05" interest payment

HANXBIO-B (03378) spent 98.85 million Hong Kong dollars to repurchase 31,200 shares on April 22nd.

SINOPHARM(01099): The net profit attributable to shareholders of China National Medicines Corporation(600511.SH) in the first quarter was 474 million yuan, a year-on-year increase of 3.32%.

GF SEC(01776): "23 GF04" interest payment redemption and delisting, "23 GF05" interest payment

HANXBIO-B (03378) spent 98.85 million Hong Kong dollars to repurchase 31,200 shares on April 22nd.

SINOPHARM(01099): The net profit attributable to shareholders of China National Medicines Corporation(600511.SH) in the first quarter was 474 million yuan, a year-on-year increase of 3.32%.